{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T11:48:33Z","timestamp":1784720913791,"version":"3.55.0"},"reference-count":0,"publisher":"Informa UK Limited","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BTT"],"DOI":"10.2147\/btt.s3180","type":"journal-article","created":{"date-parts":[[2010,8,11]],"date-time":"2010-08-11T22:47:22Z","timestamp":1281566842000},"page":"743","source":"Crossref","is-referenced-by-count":3,"title":["α-L-iduronidase therapy for mucopolysaccharidosis type I"],"prefix":"10.2147","author":[{"given":"Jakub","family":"Tolar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2008,8]]},"container-title":["Biologics: Targets & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=4420","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T18:00:15Z","timestamp":1477850415000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/alpha-l-iduronidase-therapy-for-mucopolysaccharidosis-type-i-peer-reviewed-article-BTT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/btt.s3180","relation":{},"ISSN":["1177-5475"],"issn-type":[{"value":"1177-5475","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}